Most Read Articles
Elaine Soliven, 27 Sep 2017
A second dose of kisspeptin-54 improves oocyte yield in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) treatment, according to a recent study.
23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Rachel Soon, 2 days ago

Pharmacists can and should utilize their positions within communities to provide access to an extended range of healthcare services, says an expert.

01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

CGM tied to reduced time spent in hypoglycaemia in patients with T1D

Elaine Soliven
02 Oct 2017

The use of continuous glucose monitoring (CGM) is associated with a decreased amount of time spent in hypoglycaemia in patients with type 1 diabetes (T1D), according to a study presented at EASD 2017.

This randomized crossover study analysed 161 adults with T1D (mean age 43.7 years, 45.3 percent women, mean HbA1c 70 mmol/L) who were treated with multiple daily insulin (MDI) injections. Participants were randomized to start either CGM treatment (Dexcom G4 device) or self-measurement of blood glucose (SMBG) treatment for 26 weeks, followed by a washout period of 17 weeks before crossing over to the other treatment for another 26 weeks. [EASD 2017, abstract 715]

Overall, participants spent significantly less time in hypoglycaemia (<3.9 mmol/L) during CGM treatment than during the SMBG treatment (2.8 percent vs 4.8 percent). Participants with HbA1c <3 mmol/L also had a reduced time spent in hypoglycaemia with CGM vs SMGB treatment (0.8 percent vs 1.9 percent).

When the analysis was stratified by HbA1c level, a significant reduction in time spent in hypoglycaemia was observed with CGM treatment compared with SMBG treatment during daytime (from 6:00 am to 11:59 pm, 49 vs 30 minutes) and nighttime (from midnight to 5:59 am, 19 vs 10 minutes) among participants with HbA1c <3.9 mmol/L.

Among participants with HbA1c <3 mmol/L, time spent in hypoglycaemia was also reduced in the CGM vs the SMGB arms (8 vs 18 minutes at daytime and 3 vs 9 minutes at nighttime).

“The improvement in time spent in hypoglycaemia disappeared when CGM was not used,” according to lead author Arndis Olafsdottir, a registered nurse and junior researcher from the Department of Molecular and Clinical Medicine at the University of Gothenburg, Sweden.

Based on the Hypoglycaemic Confidence Scale (HCS) responses, the patients’ confidence in managing a hypoglycaemic episode significantly improved during CGM treatment, with an improvement in HCS score from 3.27 to 3.4.

In addition, significant improvements were noted in four out of the nine items in HCS, with most patients expressing confidence in identifying and managing a hypoglycaemic event before it occurs (p=0.0033), avoiding serious hypoglycaemic complications in general (p=0.002) or in social settings (p=0.016), and carrying on with their duties despite the risk of hypoglycaemia (p=0.022).

“[Overall,] CGM [treatment] reduces time spent in nocturnal and daytime hypoglycaemia in T1D adults on MDI. CGM also increases confidence in avoiding hypoglycaemia and problems related to them,” Olafsdottir added.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elaine Soliven, 27 Sep 2017
A second dose of kisspeptin-54 improves oocyte yield in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) treatment, according to a recent study.
23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Rachel Soon, 2 days ago

Pharmacists can and should utilize their positions within communities to provide access to an extended range of healthcare services, says an expert.

01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.